Triple vessel disease is a severe form of coronary artery disease where all three major arteries supplying blood to the heart have significant blockages. “Significant” means each artery has lost at least 50% of its internal diameter due to plaque buildup. The three arteries involved are the left anterior descending artery, the left circumflex artery, and the right coronary artery. Together, these vessels are responsible for delivering oxygen-rich blood to virtually every region of the heart muscle.
Among patients who experience a certain type of heart attack (one without the most dramatic changes on an EKG), roughly 30% turn out to have triple vessel disease when doctors look inside their arteries. It represents the most extensive pattern of coronary blockage and carries real consequences for long-term survival and quality of life.
The Three Arteries Involved
Your heart muscle needs a constant supply of oxygenated blood, and three main arteries handle that job. The left anterior descending artery runs down the front of the heart and feeds the largest portion of heart muscle. The left circumflex artery wraps around the left side, supplying the back and outer wall. The right coronary artery supplies the bottom of the heart and, in most people, the area that controls your heart’s rhythm.
When plaque narrows just one of these arteries, it’s called single vessel disease. Two blocked arteries is double vessel disease. Triple vessel disease means all three have narrowed enough to restrict blood flow. The severity can vary widely: some people have 50% narrowing in all three, while others have near-complete blockages. That range matters enormously when deciding how to treat it.
Symptoms You Might Notice
The hallmark symptom is chest pain or pressure during physical activity or stress, known as angina. It can feel like squeezing, tightness, or a burning sensation in the chest, and it often spreads to the shoulders, arms, neck, jaw, or back. The pain typically fades with rest and returns when you’re active again.
Other common signs include shortness of breath (especially with exertion), unusual fatigue, dizziness, lightheadedness, cold sweats, and nausea that can mimic indigestion. Because triple vessel disease restricts blood flow across most of the heart, these symptoms tend to appear at lower levels of activity than they would with a single blocked artery.
Some people have no symptoms at all. Coronary heart disease can be “silent,” meaning the first sign of trouble is a heart attack or sudden decline in heart function. This is one reason risk factors like diabetes, high blood pressure, smoking, and family history matter so much. They signal that plaque may be building up even when you feel fine.
How It’s Diagnosed
The definitive test is a coronary angiogram, where a thin tube is threaded into the arteries of the heart and dye is injected so doctors can see blockages on X-ray in real time. This reveals exactly which arteries are narrowed, where the blockages sit, and how severe they are. A narrowing of 50% or more in all three major arteries confirms triple vessel disease.
Doctors also use a tool called the SYNTAX score to grade the complexity of the blockages. It accounts for the location, number, and characteristics of each lesion and produces a number that helps guide treatment decisions. A score of 22 or below is considered low complexity, 23 to 32 is intermediate, and 33 or above is high. In one study of patients who underwent stenting, those with the highest SYNTAX scores had a major complication rate of nearly 18%, compared to just 1.4% for those with the lowest scores. This scoring system is one of the key factors a heart team uses when recommending surgery versus a less invasive approach.
Treatment: Bypass Surgery vs. Stenting
The two main options for restoring blood flow are coronary artery bypass grafting (CABG, commonly called bypass surgery) and percutaneous coronary intervention (PCI, commonly called stenting). In bypass surgery, a surgeon uses blood vessels from elsewhere in the body to reroute blood around the blocked sections. In stenting, a cardiologist threads a small wire-mesh tube into the narrowed artery to prop it open.
For triple vessel disease, bypass surgery consistently produces better long-term outcomes. A large registry tracking patients over 10 years found that survival was 58% in the bypass group compared to 42.4% in the stenting group. When looking specifically at deaths from heart-related causes, bypass patients had a 64.5% survival rate versus 50.2% for those who received stents. Bypass surgery also leads to fewer repeat procedures down the road, since stented arteries can re-narrow over time.
Medication alone, without any procedure to restore blood flow, is associated with the worst survival. In a study of patients who had both triple vessel disease and weakened heart muscle, those treated only with medications had significantly higher mortality than those who underwent either bypass surgery or stenting. Both procedures outperformed medication-only management, but bypass surgery carried the additional advantage of lower rates of heart-related death and fewer repeat interventions compared to stenting.
Why Diabetes Changes the Equation
Diabetes is one of the strongest factors influencing how triple vessel disease is treated. People with diabetes tend to develop more diffuse, widespread plaque throughout their arteries rather than isolated blockages, which makes stenting less effective. The landmark BARI trial found that diabetic patients with multivessel disease who were treated with an early form of stenting had a five-year mortality rate of nearly 35%, significantly worse than those who had bypass surgery.
Current guidelines from the American Heart Association are direct: bypass surgery remains the preferred approach for patients with triple vessel disease and diabetes. Studies with some of the longest follow-up periods in the literature confirm that the short-term benefits seen in clinical trials translate into lasting reductions in death, heart attacks, and the need for additional procedures. A multidisciplinary heart team review is recommended for all patients with triple vessel disease, but for those with diabetes, the evidence favoring surgery is especially strong.
Long-Term Outlook and Heart Function
Triple vessel disease poses a real threat to the heart’s pumping ability over time. When large areas of heart muscle are chronically starved of blood, they weaken. This can lead to a condition where the heart’s pumping efficiency, measured as ejection fraction, drops below 40% (normal is typically 55% or higher). Once heart function declines to that level, the risks of heart failure, dangerous heart rhythms, and death all increase substantially.
Overall 10-year survival for triple vessel disease across all treatment approaches is roughly 50%. That number improves meaningfully with bypass surgery and worsens with medication alone or in patients with complex blockage patterns and high SYNTAX scores. Age, kidney function, diabetes, and how much heart muscle has already been damaged all factor into an individual’s prognosis.
The encouraging reality is that revascularization, especially bypass surgery, can halt or slow the decline in heart function by restoring blood flow to areas of the heart that are still viable. Patients who are treated before irreversible damage sets in tend to do considerably better than those diagnosed after the heart muscle has already scarred.